Clinical Trial Update: A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for escitalopram in children and adolescents with generalized anxiety disorder has completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder in Children and Adolescents

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: AbbVie | Conditions: Anxiety Disorders,Generalized Anxiety Disorder | Phase 4 | Status: COMPLETED | Results posted: 2022-11-14